News
Radiotherapy responses may be improved with targeted immunotherapy, study suggests
A new study suggests that targeted immunotherapy could make cancers that are resistant to radiotherapy more responsive to treatment.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
A new study suggests that targeted immunotherapy could make cancers that are resistant to radiotherapy more responsive to treatment.